Altitude Lab, the platform-first biotech-startup accelerator founded by Recursion (NASDAQ: RXRX), announced today that its portfolio companies have collectively raised more than $205 million in ...
The sudden resolution of a well-known conjecture highlights the growing adoption of AI as an assistant in high-level ...
Thanks to some surprising advances, mathematicians are starting to realize that artificial intelligence could radically alter ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...